BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 8584082)

  • 1. Retrograde perfusion of the cerebral vein with antioxidant LY231617 reduces brain damage in the rat focal ischemia model.
    Nagao T; Yamamoto YL; Inoue N; Ito Y
    Neurol Med Chir (Tokyo); 1995 Dec; 35(12):861-8. PubMed ID: 8584082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of retrograde infusion with LY231617 in a rat middle cerebral artery occlusion model.
    Inoue N; Yamamoto YL; Ito Y; Clemens JA; Panetta JK; Diksic M
    Can J Neurol Sci; 1996 Aug; 23(3):175-83. PubMed ID: 8862838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of retrograde perfusion of the cerebral vein for attenuating neuronal injury after transient ischemia following reperfusion in the rat brain.
    Inoue N; Yamamoto YL; Korematsu K; Goto S; Nagahiro S; Oyama T; Yamada K; Ushio Y
    Neurol Med Chir (Tokyo); 1997 Mar; 37(3):243-9. PubMed ID: 9095624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antioxidant LY231617 enhances electrophysiologic recovery after global cerebral ischemia in dogs.
    Toung TJ; Bhardwaj A; Wang M; Kirsch JR; Traystman RJ
    Crit Care Med; 2000 Jan; 28(1):196-201. PubMed ID: 10667522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The antioxidant LY231617 reduces global ischemic neuronal injury in rats.
    Clemens JA; Saunders RD; Ho PP; Phebus LA; Panetta JA
    Stroke; 1993 May; 24(5):716-22; discussion 722-3. PubMed ID: 8488528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroprotective effects of the antioxidant LY231617 and NO synthase inhibitors in global cerebral ischaemia.
    O'Neill MJ; Hicks C; Ward M; Panetta JA
    Brain Res; 1997 Jun; 760(1-2):170-8. PubMed ID: 9237532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transvenous perfusion of the brain with verapamil during focal cerebral ischemia in rats.
    Ueda T; Yamamoto YL; Diksic M
    Stroke; 1989 Apr; 20(4):501-6. PubMed ID: 2929027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-induced neuroprotection from global ischemia is associated with prevention of persistent but not transient activation of nuclear factor-kappaB in rats.
    Clemens JA; Stephenson DT; Yin T; Smalstig EB; Panetta JA; Little SP
    Stroke; 1998 Mar; 29(3):677-82. PubMed ID: 9506612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of retrograde perfusion of the cerebral vein with verapamil after focal ischemia in rat brain.
    Hosaka T; Yamamoto YL; Diksic M
    Stroke; 1991 Dec; 22(12):1562-6. PubMed ID: 1962332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue distribution of LY231617, an antioxidant with neuroprotectant activity, in the rat.
    Brewster ME; Anderson WR; Estes KS; Bodor NS; Pop E; Panetta JA
    J Pharm Sci; 1995 Jul; 84(7):791-3. PubMed ID: 7562425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of bypass between extracerebral artery and cerebral vein with retrograde verapamil infusion into focal cerebral ischemic tissue in rats.
    Yamamoto YL; Ueda T; Shimauchi M; Diksic M
    Neurosurgery; 1991 Nov; 29(5):719-25; discussion 725-6. PubMed ID: 1961402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase C in focal ischemic rat brain: dual autoradiographic analysis of [14C]iodoantipyrine (IAP) and [3H]phorbol-12,13-dibutyrate (PDBu).
    Tohyama Y; Sako K; Yonemasu Y
    Brain Res; 1997 Mar; 750(1-2):155-60. PubMed ID: 9098540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of LY231617 and angiotensin IV on ischemia-induced deficits in circular water maze and passive avoidance performance in rats.
    Wright JW; Clemens JA; Panetta JA; Smalstig EB; Weatherly LA; Kramár EA; Pederson ES; Mungall BH; Harding JW
    Brain Res; 1996 Apr; 717(1-2):1-11. PubMed ID: 8738247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of local cerebral blood flow, phorbol 12,13-dibutyrate binding activity, and histological damage during acute focal ischaemia in rat brain. A pathophysiology of acute focal ischaemia: Part 1.
    Inoue N; Yamamoto YL; Nagao T; Goto S; Nagahiro S; Ushio Y
    Acta Neurochir (Wien); 1996; 138(9):1118-24; discussion 1124-5. PubMed ID: 8911551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of retrograde perfusion of the brain with combined drug therapy after focal ischemia in rat brain.
    Shimauchi M; Yamamoto YL
    Stroke; 1992 Dec; 23(12):1805-10; discussion 1810-1. PubMed ID: 1448832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of LY231617 protection against hydrogen peroxide toxicity.
    Fuson KS; Mark RJ; Panetta JA; May PC
    J Neurochem; 1999 Mar; 72(3):1154-60. PubMed ID: 10037488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of sulfated glycoprotein-2 (clusterin) and glial fibrillary acidic protein (GFAP) RNA expression following transient global ischemia is differentially attenuated by LY231617.
    May PC; Clemens JA; Panetta JA; Smalstig EB; Stephenson D; Fuson KS
    Brain Res Mol Brain Res; 1996 Nov; 42(1):145-8. PubMed ID: 8915593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tolerance of the cerebral venous system to retrograde perfusion pressure in focal cerebral ischemia in rats.
    Ueda T; Yamamoto YL; Takara E; Diksic M
    Stroke; 1989 Mar; 20(3):378-85. PubMed ID: 2922777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of GABA(A) receptor blockade on regional cerebral blood flow and blood-brain barrier disruption in focal cerebral ischemia.
    Chi OZ; Hunter C; Liu X; Chi Y; Weiss HR
    J Neurol Sci; 2011 Feb; 301(1-2):66-70. PubMed ID: 21094956
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel complement C1 inhibitor BSF468248 does not improve brain damage after cortical vein occlusion.
    Kaido T; Heimann A; Kempski O
    Methods Find Exp Clin Pharmacol; 2003 Oct; 25(8):611-6. PubMed ID: 14671678
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.